Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.5200
-0.0013 (-0.25%)
At close: Jun 3, 2026, 4:00 PM EDT
0.5247
+0.0047 (0.90%)
Pre-market: Jun 4, 2026, 8:02 AM EDT
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $12.22 million as of June 4, 2026. Its market cap has decreased by -13.88% in one year.
Market Cap
12.22M
Enterprise Value
12.01M
1-Year Change
-13.88%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $12.22M, a decrease of -72.23%. That is a compound annual growth rate of -60.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 12.22M | 34.75% |
| Dec 31, 2025 | 9.07M | -79.39% |
| Jan 15, 2025 | 44.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| McKesson | 88.54B |
| Cencora | 51.56B |
| Cardinal Health | 45.63B |
| Henry Schein | 8.69B |
| Akso Health Group | 1.37B |
| Accendra Health | 212.14M |
| Empro Group | 144.63M |
| 111, Inc. | 47.77M |